Sponsors

Mycoplasma pneumoniae monoclonal antibodies

Mycoplasma pneumoniae is a parasitic pathogen of the human respiratory tract. This bacterium lacks a cell wall and thus many antibiotics that inhibit cell wall synthesis are ineffective as treatment. M. pneumoniae causes atypical pneumonia and affects children and young adults most commonly. The organism adheres to respiratory epithelial cells via several adhesins. The P1 adhesin is a major virulence factor of this organism.

ViroStat has now released a new set of monoclonal antibodies to the P1 adhesin of M. pneumoniae. These new antibodies function well in immunofluorescence antibody (IFA) staining and as enzyme-linked immunosorbent assay (ELISA) pairs for the detection of the P1 antigen. These antibodies join the existing collection of ViroStat M. pneumoniae antibody reagents.
www.virostat-inc.com

Latest Issues

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026